Raia Drogasil SA
BOVESPA:RADL3
Raia Drogasil SA
BOVESPA:RADL3
Price:
26.59
BRL
1.22%
Market Closed
Market Cap:
R$45.7B
Relative Value
The Relative Value of one
RADL3
stock under the Base Case scenario is
24.94
BRL.
Compared to the current market price of 26.59 BRL,
Raia Drogasil SA
is
Overvalued by 6%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RADL3
Relative Value
Base Case
24.94
BRL
Overvaluation 6%
Multiples Across Competitors
RADL3 Competitors Multiples
Raia Drogasil SA Competitors
Raia Drogasil SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45.2B BRL | 1.1 | 37.2 | 12 | 21.9 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.5B ZAR | 1.6 | 25.5 | 12.5 | 17.6 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.3B ZAR | 0.8 | 25.7 | 10.4 | 15.7 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.1 | -1.6 | 3 | 5.1 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY | 1 | 32.3 | 14.1 | 20.9 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY | 1 | 18.6 | 8.7 | 11.1 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 1.7 | 20.7 | 10.4 | 19.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.7B CNY | 1.3 | 18.7 | 14.5 | 14.5 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 0.5 | 34.3 | 9.1 | 15.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
640.3B JPY | 0.6 | 15.1 | 9.2 | 13 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
570.5B JPY | 0.5 | 18.3 | 8.8 | 13.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
